Triamcinolone acetonide and Renal tubular atrophy - a phase IV clinical study of FDA data
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Triamcinolone Acetonide?
Triamcinolone acetonide has active ingredients of triamcinolone acetonide. It is used in eczema. Currently, eHealthMe is studying from 16,556 Triamcinolone acetonide users.
What is Renal Tubular Atrophy?
Renal tubular atrophy (wasting of kidney tubules) is found to be associated with 473 drugs and 211 conditions by eHealthMe. Currently, we are studying 1,005 people who have Renal tubular atrophy.
Do you take Triamcinolone acetonide and have Renal tubular atrophy?Check whether Renal tubular atrophy is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Triamcinolone acetonide side effects by duration, gender and age:
- Triamcinolone acetonide side effects (16,556 reports)
Renal tubular atrophy treatments and more:
- Renal tubular atrophy (1,005 reports)
All the drugs that are associated with Renal tubular atrophy:
All the conditions that are associated with Renal tubular atrophy:
How the study uses the data?
The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Triamcinolone acetonide) and Triamcinolone acetonide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ziac and Colonic Polyp - 9 seconds ago
- Metoclopramide Hydrochloride and Aldactone drug interaction - 10 seconds ago
- Metoclopramide and Blood Creatine Decreased - 11 seconds ago
- Clonidine and Gastritis Haemorrhagic - 15 seconds ago
- Ofev and Blood Creatinine Increased - 21 seconds ago
- Lupron Depot and Celestone drug interaction - 23 seconds ago
- Aspirin and Flavin drug interaction - 52 seconds ago
- Tenofovir Disoproxil Fumarate and Orencia drug interaction - 56 seconds ago
- Lactic Acid and Ursodeoxycholic Acid drug interaction - 59 seconds ago
- Maxolon and Tamoxifen Citrate drug interaction - a minute ago